If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCranswick Regulatory News (CWK)

Share Price Information for Cranswick (CWK)

Share Price is delayed by 15 minutes
Get Live Data
5,610.00    50.00 (0.90%)
Bid:
5,610.00
Ask:
5,620.00
Spread: 10.00 (0.178%)
Market Cap: £3.00b
CWK Live PriceLast checked at - London Stock Exchange

Intraday Cranswick Share Chart

Director Appointments

23 Jun 2022 07:00

RNS Number : 8624P
Cranswick PLC
23 June 2022
 

23 June 2022

Cranswick plc(the "Company" or "the Group")

Director Appointments

Cranswick plc, a leading UK food producer, announces the appointment of Yetunde Hofmann as an independent Non-Executive Director of the Company and of Christopher Aldersley as an Executive Director of the Company, both with effect from 1 August 2022.

Yetunde Hofmann

Yetunde is the Managing Director of Synchrony Development Consulting, an international leadership and change consultancy that partners with leaders to facilitate strategy, change, diversity and inclusion and the founder of Solaris Global Executive Leadership Development. She is also a Trustee at the Institute of Business Ethics (IBE) and is a visiting fellow at the University of Reading's Henley Business School of Marketing and Reputation.

On appointment, Yetunde will become a member of the Audit, Remuneration, Nomination and ESG committees.

Yetunde is an independent Non-Executive Director at Treatt plc. No other information is required to be disclosed pursuant to Listing Rule 9.6.13R in relation to Yetunde Hofmann's appointment as a Non-Executive Director of the Company.

Christopher Aldersley

Chris joined Cranswick in 1998 and since then has undertaken a variety of senior management roles, becoming the Group's Chief Operating Officer in 2015. Chris has responsibility for managing the operations at the Group's four primary processing and sixteen added value facilities and also for its agricultural operations, which support the Group's vertically integrated supply chain strategy.

The appointment of Chris to the Board recognises his contribution to the Group and central importance of his role going forward as a member of the Board to the delivery of the Group's long-term strategy.

On appointment, Chris will become a member of the ESG committee.

No other information is required to be disclosed pursuant to Listing Rule 9.6.13R in relation to Chris Aldersley's appointment as an Executive Director of the Company.

Tim Smith, Chairman of Cranswick plc, commented:

"I am delighted that Yetunde and Chris will join our Board.

"Yetunde's experience will complement our existing Board. She has an established track record of mentoring and developing performance, talent and leadership strategies across a range of organisations, which will be invaluable to Cranswick.

"Chris's role at Cranswick has grown with the rapid development of the Group and he has been central to facing the challenges presented in recent times by Brexit and the COVID-19 pandemic. Chris helps deliver our Second Nature sustainability strategy. I am pleased his contribution is recognised with his appointment to the Board.".

Enquiries:

Cranswick plc

01482 275 000

Mark Bottomley, Chief Financial Officer

Powerscourt

020 7250 1446

Nick Dibden / Nick Hayns/Chloe Retief

cranswick@powerscourt-group.com

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BOAFLFEERTIFFIF
Date   Source Headline
30th Jan 20147:00 amRNSInterim Management Statement
27th Jan 20142:33 pmRNSHolding(s) in Company
20th Jan 20142:41 pmRNSAdditional Listing
12th Dec 20132:53 pmRNSDividend Declaration
9th Dec 20131:44 pmRNSDirector/PDMR Shareholding
25th Nov 20137:00 amRNSHalf Yearly Report
7th Oct 20137:00 amRNSFirst Half Trading Statement
1st Oct 20135:10 pmRNSBlock Listing Six Monthly Return
1st Oct 20135:09 pmRNSBlock Listing Six Monthly Return
23rd Sep 20135:04 pmRNSDirector/PDMR Shareholding
23rd Sep 20135:03 pmRNSDirector/PDMR Shareholding
23rd Sep 20135:02 pmRNSDirector/PDMR Shareholding
20th Sep 20134:35 pmRNSPrice Monitoring Extension
16th Aug 20139:55 amRNSAdditional Listing
1st Aug 20133:41 pmRNSDirector Declaration
30th Jul 201310:22 amRNSResult of AGM
29th Jul 20137:00 amRNSInterim Management Statement
11th Jul 20132:52 pmRNSDirector/PDMR Shareholding
10th Jul 20131:34 pmRNSDividend Declaration
5th Jul 201311:50 amRNSTotal Voting Rights
10th Jun 20133:48 pmRNSDirector/PDMR Shareholding
10th Jun 201311:42 amRNSDirector/PDMR Shareholding
20th May 20138:47 amRNSDirectorate Change
20th May 20137:00 amRNSFinal Results
13th May 20139:27 amRNSTotal Voting Rights
30th Apr 20137:00 amRNSAcquisition of Pig Rearing Business
10th Apr 201310:05 amRNSAdditional Listing
4th Apr 20137:00 amRNSFourth Quarter Trading Statement
2nd Apr 20134:57 pmRNSBlocklisting Six Monthly Return
2nd Apr 20134:06 pmRNSTotal Voting Rights
28th Mar 20134:24 pmRNSDirector/PDMR Shareholding
31st Jan 20137:00 amRNSThird Quarter Interim Management Statement
30th Jan 20133:23 pmRNSDirector/PDMR Shareholding
30th Jan 20133:22 pmRNSDirector/PDMR Shareholding
30th Jan 20133:21 pmRNSDirector/PDMR Shareholding
30th Jan 20133:20 pmRNSDirector/PDMR Shareholding
11th Jan 20137:00 amRNSAdditional Listing
12th Dec 20124:54 pmRNSDividend Timetable
10th Dec 201210:42 amRNSHolding(s) in Company
6th Dec 201211:18 amRNSTotal Voting Rights
26th Nov 20127:00 amRNSHalf Yearly Report
8th Oct 20127:00 amRNSTrading Statement
3rd Oct 20128:42 amRNSBlocklisting Interim Review
11th Sep 20121:40 pmRNSDirector/PDMR Shareholding
11th Sep 20121:39 pmRNSDirector/PDMR Shareholding
11th Sep 20121:37 pmRNSDirector/PDMR Shareholding
11th Sep 20121:36 pmRNSDirector/PDMR Shareholding
29th Aug 20128:09 amRNSHolding(s) in Company
24th Aug 20122:58 pmRNSAdditional Listing
6th Aug 201210:37 amRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.